Junji Tanaka

14.8k total citations
534 papers, 10.5k citations indexed

About

Junji Tanaka is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Junji Tanaka has authored 534 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Hematology, 102 papers in Immunology and 80 papers in Oncology. Recurrent topics in Junji Tanaka's work include Hematopoietic Stem Cell Transplantation (113 papers), Acute Lymphoblastic Leukemia research (55 papers) and Immune Cell Function and Interaction (53 papers). Junji Tanaka is often cited by papers focused on Hematopoietic Stem Cell Transplantation (113 papers), Acute Lymphoblastic Leukemia research (55 papers) and Immune Cell Function and Interaction (53 papers). Junji Tanaka collaborates with scholars based in Japan, United States and United Kingdom. Junji Tanaka's co-authors include Masahiro Imamura, Shuji Kanemasa, Masahiro Asaka, Hiroshi Shimoda, Satoshi Hashino, Yoshiko Atsuta, Takayoshi Tobe, Eiji Wada, Yoji Oderaotoshi and Kazue Ozawa and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Junji Tanaka

515 papers receiving 10.2k citations

Peers

Junji Tanaka

HEMAT

IMMUN

ONCOL

EPIDE

Peter Schäfer United States

Giuseppe Leone Italy

Michael J. Hickey Australia

David Ginsburg United States

Mauro Magnani Italy

James G. White United States

Bruce Furie United States

Federico Bussolino Italy

Francis Castellino United States

Barbara C. Furie United States

Peter Schäfer United States

Junji Tanaka

2.9k ×1.2

HEMAT

2.3k ×1.1

IMMUN

4.7k ×2.7

2.6k ×1.6

ONCOL

1.1k ×0.7

EPIDE

Citations per year, relative to Junji Tanaka Junji Tanaka (= 1×) peers Peter Schäfer

Countries citing papers authored by Junji Tanaka

Since Specialization

Citations

This map shows the geographic impact of Junji Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Tanaka more than expected).

Fields of papers citing papers by Junji Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Tanaka. The network helps show where Junji Tanaka may publish in the future.

Co-authorship network of co-authors of Junji Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Tanaka. A scholar is included among the top collaborators of Junji Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Tanaka. Junji Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagiwara, Shotaro, et al.. (2024). Elotuzumab Enhances CD16‐Independent NK Cell‐Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell‐Enhancing Genes. Journal of Immunology Research. 2024(1). 1429879–1429879. 4 indexed citations

Ishida, Tadao, Kiyoshi Ando, Rikio Suzuki, et al.. (2023). Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma. International Journal of Hematology. 117(5). 729–737. 15 indexed citations

Konuma, Takaaki, Hidehiro Itonaga, Ken Ishiyama, et al.. (2023). Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?. Bone Marrow Transplantation. 58(8). 893–906. 2 indexed citations

Ishibashi, Mariko, Hiroshi Handa, Makoto Sasaki, et al.. (2023). The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma. Experimental Hematology. 121. 38–47.e2. 2 indexed citations

Shimomura, Yoshimitsu, Masahiko Hara, Takaaki Konuma, et al.. (2021). Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients. Bone Marrow Transplantation. 56(10). 2510–2517. 9 indexed citations

Kurosawa, Shuhei, Shohei Mizuno, Yasuyuki Arai, et al.. (2021). Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. Blood Cancer Journal. 11(9). 159–159. 3 indexed citations

Nishiwaki, Satoshi, Yu Akahoshi, Shuichi Mizuta, et al.. (2021). Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2. Blood Advances. 5(2). 584–592. 6 indexed citations

Kaito, Satoshi, Yuho Najima, Kaito Harada, et al.. (2020). Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. Bone Marrow Transplantation. 55(7). 1337–1346. 5 indexed citations

Imaizumi, Yoshitaka, Masako Iwanaga, Kisato Nosaka, et al.. (2020). Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study. Cancer Science. 111(12). 4567–4580. 48 indexed citations

10.

Hagiwara, Shotaro, et al.. (2017). Phenotypic Analysis of NK Cell in Multiple Myeloma Patients. Blood. 130. 5384–5384. 1 indexed citations

11.

Islam, Md. Monarul, Taisuke Matsumoto, Junji Tanaka, et al.. (2016). Demethylation of 5,n-di-tert-butyl-8,n-dimethoxy[2.n]metacyclophane-1-ynes with BBr3 to afford novel [n]benzofuranophanes. Journal of Molecular Structure. 1122. 247–255. 10 indexed citations

12.

Takahata, Mutsumi, Satoshi Hashino, Katsuya Fujimoto, et al.. (2012). [Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].. PubMed. 53(12). 1983–90. 4 indexed citations

13.

Tanaka, Kazunari, Shoko Nishizono, Shizuka Tamaru, et al.. (2009). Anti-Obesity and Hypotriglyceridemic Properties of Coffee Bean Extract in SD Rats. Food Science and Technology Research. 15(2). 147–152. 34 indexed citations

14.

Tanaka, Junji, et al.. (2007). Suppressive Effect of Defatted Kiwi Fruit Seed Extract on Acute Inflammation and Skin Pigmentation. Food Science and Technology Research. 13(4). 310–314. 6 indexed citations

15.

Atsuta, Yoshiko, Ritsuro Suzuki, Ayami Yoshimi, et al.. (2007). [The unification of hematopoietic stem cell transplantation registry in Japan and establishment of the TRUMP system].. PubMed. 48(11). 1462–9. 1 indexed citations

16.

Tomita, Masahiro, T. Taniguchi, Junji Tanaka, et al.. (2003). Poster Session. Human Antibodies. 12(1-2). 37–50. 1 indexed citations

17.

Hashino, Satoshi, et al.. (1996). Renal Salmonella enteritidis abscess in a patient with severe aplastic anemia after allogeneic stem cell transplantation.. PubMed. 18(4). 807–8. 5 indexed citations

18.

Imamura, Masahiro, Satoshi Hashino, Hirohito Kobayashi, et al.. (1994). Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.. PubMed. 13(2). 130–130. 107 indexed citations

19.

Kudomi, Nobuyuki, H. Ejiri, Kosei Nagata, et al.. (1992). Double beta decays of Mo100 to excited states in Ru100. Physical review. C. 46(6). 2132–2135. 1 indexed citations

20.

Tanaka, Junji, et al.. (1980). Stimulation of Mitochondrial Phosphorylative Activity in the Regenerating Rabbit Liver following Oral Antibiotic Treatment. European Surgical Research. 12(2). 87–94. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact